|
|
||||||||
1 Departments of Pediatrics, Physiological Sciences, and 3 Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk 23501, and 2 Department of Chemistry, Old Dominion University, Norfolk, Virginia 23529
| |
ABSTRACT |
|---|
|
|
|---|
The postnatal pattern of renal endothelial nitric oxide synthase (eNOS) is unknown. The purpose of this study was to characterize eNOS expression during maturation and compare this to neuronal NOS (nNOS). The experiments measured whole kidney eNOS mRNA expression by RT-PCR and protein content by Western blot, as well as cortical and medullary protein content in piglets at selected postnatal ages and in adult pigs. Whole kidney eNOS mRNA was compared with nNOS. Whole kidney eNOS expression decreased from the newborn to its lowest at 7 days, returning by 14 days to adult levels. This eNOS mRNA pattern contrasted with nNOS, which was highest at birth, and progressively decreased to its lowest level in the adult. At birth, cortical eNOS protein was greater than medullary, contrasting with the adult pattern of equivalent levels. In conclusion eNOS is developmentally regulated during early renal maturation and may critically participate in renal function during this period. The eNOS developmental pattern differs from nNOS, suggesting that these isoforms may have different regulatory factors and functional contributions in the postnatal kidney.
neuronal; gene expression; protein content; development
| |
INTRODUCTION |
|---|
|
|
|---|
NITRIC OXIDE (NO) has a greater role in renal function during the period of maturation after birth compared with the adult (21). NO counterbalances the action of highly activated intrarenal systems, such as the renin angiotensin system (20, 21, 23). In this enhanced functional role NO protectively maintains neonatal renal blood flow (RBF) and glomerular filtration rate (GFR) under both physiological and pathophysiological conditions (21). The mechanisms producing the increased participation of NO during postnatal renal development are not fully known. Our hypothesis is that the greater functional role of NO in the developing kidney is due to a differing expression of the NO synthesizing enzyme, nitric oxide synthase (NOS), compared with the adult.
NO, functioning as an efficient intracellular messenger, is produced from the single amino acid precursor L-arginine and is mediated by NOS. In the kidney the three isoforms of NOS: 1) neuronal (nNOS, NOS 1), 2) inducible (iNOS, NOS 2), and 3) endothelial (eNOS, NOS 3) demonstrate specific localization within the nephron (1, 12). The nNOS isoform is predominantly detected in tubular epithelial cells of the macula densa and inner medullary collecting duct. This isoform has been characterized in the adult in several species (13) and in developing kidney in the rat (7) and pig (22). After birth nNOS mRNA gene expression and protein follow a parallel, distinct pattern (22). The highest expression of whole kidney nNOS occurs immediately at birth. Thereafter, nNOS expression progressively declines with age to the lowest levels in the adult (22). Furthermore, nNOS undergoes differential corticomedullary regulation. Medullary nNOS is proportionately greater than cortical in the immature kidney than the adult (22). Given the unique developmental pattern of nNOS, this isoform may contribute to the functional significance of NO throughout the entire period of renal maturation.
However, other NOS isoforms may contribute to neonatal renal hemodynamics as well, in particular eNOS. This isoform has been localized to the renal vasculature in the adult (12), including the glomerular afferent and efferent resistance arterioles and vasa recta. eNOS is also found in tubular structures: proximal tubule, medullary thick ascending limb, and collecting ducts (12). Furthermore, eNOS expression and activity may be greater in the medulla than the cortex in the adult rat (24). However, the expression of eNOS during postnatal renal maturation has not been studied.
The purpose of these experiments therefore was to characterize eNOS expression throughout the entire period of postnatal renal maturation and compare this pattern to that of nNOS. The experiments quantified whole kidney eNOS mRNA expression by RT-PCR and eNOS protein content by Western blot in piglets (newborn, 3, 7, 14, and 21 days old) and in adult pigs. Cortical and medullary eNOS protein was quantified in newborn and 7-day-old piglets and in adult pigs. Additionally, to compare the developmental patterns of eNOS and nNOS in the same tissue specimen, the relative abundance of eNOS and nNOS mRNA by RT-PCR was measured in piglets (newborn and 7 days old) and in adult pigs.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. All experiments were performed on mixed breed swine obtained from the same local vendor. All animals were transported and housed under the same conditions. Piglets were procured as littermate pairs. Kidneys of preweanling piglets (2 h, 3, 7, 10, and 14 days old) were harvested on arrival. Kidneys of weaned piglets (21 days old) and adults >70 days of age were harvested 24 h after arrival to allow for dietary and climactic adjustment.
Tissue preparation.
After death with a euthanizing solution, 390 and 50 mg/ml phentoin,
kidneys are immediately removed from the animals (piglets and adult
pigs) and coronally sectioned. The coronal sections are cut into
segments that conserve the corticomedullary architecture from the lower
and upper pole and mid-kidney regions for whole kidney analysis. Cortex
and medulla were carefully separated under a dissecting microscope. The
prepared tissue is then immediately frozen in liquid nitrogen and
stored at
80°C for future use in experiments.
Western blot analysis. Western blots were performed on whole kidney homogenates, cortex, and medulla from tissue processed as previously described. Whole kidney Western blots were performed on piglets (newborn, 3, 7, 14, and 21 days old) and adult pigs. These age groups were selected for this study to provide a representative analysis of the postnatal developmental spectrum. Separate experiments involved Western blots on the cortex and medulla in piglets (newborn and 7 days old) and adult pigs. These ages were chosen based on the data obtained from the larger age group sampling. The protein concentration of the homogenates was measured using Bio-Rad Protein Assay (Bio-Rad Laboratories, Richmond, CA). Ten micrograms of the total protein was loaded and separated on a 6% denaturing SDS-PAGE. The proteins were then blotted onto nitrocellulose (Hy-Bond, Amersham, Arlington Heights, IL) by dry electroblot for 1 h. The blots were allowed to air dry for 1 h and then blocked overnight at 4°C with 6% nonfat dry milk in Tris-saline buffer. Because antiporcine eNOS is not commercially available, we used a human eNOS antibody. Selection of this antibody is based on 90% homology of the human protein to the porcine eNOS protein. The difference between the human and porcine eNOS protein is only a total of 15 amino acids. The human eNOS antibody used for this Western blot analysis was purchased from Alexis Biochemicals (San Diego, CA), who provided the amino acid analysis. The blots were then washed twice in Tris-saline buffer and then incubated with the human eNOS isoform-specific antibody at a dilution of 1:4,000 in Tris-saline buffer for 2 h at room temperature. The blots were washed four times in Tris-saline buffer and incubated with horseradish peroxidase-conjugated rabbit immunoglobulin (Amersham, Piscataway, NJ) antibody for 1 h at room temperature. Finally, the blots were washed four additional times in Tris-saline buffer, and the specific proteins were detected by enhanced chemiluminesence (Amersham). Pulmonary artery from newborn animals was used as a positive control. Negative controls were performed as described previously without the primary antibody, and on recombinant human Zp3, a zona pellucida protein that does not contain eNOS.
Isolation of total RNA.
The method for isolation of RNA is described by Cathala et al.
(5). Briefly, frozen tissues obtained by methods described previously (~0.5 g) are crushed before being transferred into centrifuge tubes containing 4 ml of lysis buffer [5 M guanidine monothiocyanate, 10 mM EDTA, 50 mM Tris · HCl, pH 7.5, and 8% (vol/vol)
-mercaptoethanol added just before use]. The tissues are
homogenized and then centrifuged at 2,000 g at 4°C for 10 min. Seven volumes of 4 M LiCl is added to the supernatants, mixed well, and left at 4°C overnight. The mixture is pelleted by
centrifugation at 11,000 g, 4°C for 90 min, resuspended in
7 ml of 3 M LiCl, and centrifuged at 11,000 g, 4°C for an
additional 60 min. The pellets are resuspended in 4 ml of cold
solubilization buffer (0.1% SDS, 1 mM EDTA, and 10 mM
Tris · HCl, pH 7.5). A 0.05 volume of 7.5 M ammonium acetate is
added to RNAs samples and then extracted with one volume of
phenol/chloroform (1:1). One volume of cold 2-propanol is added to the
RNA sample and kept at
20°C overnight. After centrifugation, the
RNA sample is air dried and resuspended in diethyl pyrocarbonate
water. The concentration of RNA is measured using
spectrophotometer at 260 and 280 nm optical density. Integrity of RNA is determined by agarose gel electrophoresis.
Quantitative RT-PCR. Quantitative RT-PCR was performed on whole kidney homogenates from tissue processed as described previously. Separate experiments were performed on samples from piglets (newborn, 3, 7, 14, and 21 days old) and adult pigs. These age groups were selected for this study to provide a representative analysis of the postnatal developmental spectrum. Quantitative RT-PCR was also performed on whole kidney samples obtained from the same animal in piglets (newborn and 7 days old) and adult pigs. These ages were chosen based on the data obtained from the larger age group sampling. A pair of primers specifically complementary to porcine eNOS cDNA is employed. The sense strand primer is located between base +1818 and +1839 (5'-AGGAGGTGACAAGCCGCA TAC-3') and antisense is located between base +2236 and +2256 (5'-AAGATGAGATGAGAGAGA TAC-3'). Meanwhile, sense strand primer of nNOS is located at base +1586 to +1606 (5'-TCAAGGTCAAGAAC TGGGAG-3', according to human nNOS sequence) and antisense is located at base +1940 to +1960 (5'-CCTGCAGCTT GGACCACTGG-3'). Ten micrograms of total RNA is hybridized with oligo(dT) in RT buffer (BRL), and the reaction carried out with Moloney-Murine Leukemia Virus reverse transcriptase (BRL) for 2 h at 37°C. The reaction terminates by heating for 15 min at 68°C and is diluted to a final volume of 100 µl. Ten microliters of the reverse transcription reaction are added to a final volume of 50 µl in 10 mM Tris · HCI, pH 8.4; 2.5 mM MgCI2, 250 µM dATP, dGTP, dCTP, and TTP; 0.5 µg each of sense and antisense strand primers, and 2.5 U Taq polymerase (Perkin Elmer/Cetus, Norwalk, CT). The polymerase amplification is carried out for 30 cycles (30 s) and a 72°C denaturing cycle (1 min), a 55°C annealing cycle (33 s), and 72°C extension cycle (2 min), followed by a final extension at 72°C for 10 min. The PCR products are then visualized by electrophoresis in an agarose gel with ethidium bromide. RNA sample from newborn piglet without RT was used as a negative control. [35S]dCTP is included for the RT-PCR quantitation studies. [35S]dCTP (1 µM) is used for each reaction. For the standard curve, eNOS cDNA purified from gel, is quantitated by measuring the absorbance at 260 nm and used as DNA template for quantitation. The RT-PCR products are separated on a 4% polyacrylamide gel, and radioactivity is quantitated by a Molecular Dynamic phosphorImager (Image Quant Software Program). The level of light emission (proportional to radioactivity) is plotted against the known amount of standard DNA to generate a regression line from which the content of the specific PCR product in each sample is computed. In parallel experiments, the same amount of different porcine kidney samples is performed by RT-PCR with a pair of human cyclophilin primers as an internal control.
Statistical analysis. For all age groups, experiments were performed on kidney samples obtained from five separate animals. All assays were repeated at least three times. Results are expressed as means ± SE, with statistical significance at P < 0.05. The data were evaluated by analysis of variance. Comparisons among means were performed using Newman-Keuls test.
| |
RESULTS |
|---|
|
|
|---|
Whole kidney eNOS mRNA levels by quantitative RT-PCR.
Whole kidney eNOS RT-PCR was determined in piglets (newborn, 3, 7, 14, and 21 days old) and adult pigs. RT-PCR results in a single
amplification band at 439 bp only from the tested samples but not from
the RNA without RT (negative control) as shown in Fig.
1. To quantify the eNOS mRNA level by
RT-PCR, a standard curve was generated using eNOS cDNA as a DNA
template. To determine the optimum amount of DNA template for PCR as
well as the optimum PCR cycle, a series of PCR experiments with
different concentration of eNOS cDNA and different PCR cycles were
performed. As shown in Fig. 1, when 0.125-8 pg of DNA template and
35 PCR cycles were used, the linear relationship between the
concentration and incorporation with [35S]dCTP was
obtained. The expression of eNOS mRNA is higher in the newborn kidney
and significantly decreases to the lowest level at day 7.
After this decrease, the expression level of eNOS mRNA significantly
increases in the developing porcine kidney by day 14. The
eNOS mRNA expression remains at this level throughout maturation to the
adult.
|
Whole kidney eNOS protein content by Western blot.
Western blot analysis was performed throughout the renal maturational
spectrum to determine whether the protein content of eNOS in the
developing porcine kidney has the same pattern as mRNA expression. As
shown in Fig. 2, Western blot analysis of samples of whole kidney homogenates demonstrated that eNOS protein content has a pattern similar to that of mRNA gene expression. The
higher protein content is first observed in newborn and then significantly decreases to the lowest level at day 7. The
eNOS protein content increases to day 14 and remains at this
level through to the adult.
|
Cortical and medullary eNOS protein content by Western blot.
Based on the observation that whole kidney eNOS dropped to the lowest
level at 7 days of age, eNOS protein content was measured in the cortex
and medulla in animals of selected ages. Therefore, cortical and
medullary eNOS protein content was determined in piglets (newborn and 7 days old) and adult pigs. The pattern of changes in eNOS protein
content in cortex and medulla during postnatal renal development are
demonstrated in Fig. 3. Cortical eNOS is greater than medullary at birth and 7 days of age, compared with the
adult, which shows the reverse pattern, with medullary relatively equivalent to cortical. The newborn demonstrated the greatest amount of
cortical eNOS. Medullary eNOS was greatest in the adult and least in
the 7-day-old piglet.
|
Comparison of whole kidney mRNA levels between nNOS and eNOS by
RT-PCR.
Our previous description of the postnatal renal developmental pattern
of nNOS (22) and the results from the studies of eNOS expression were obtained from experiments performed in separate kidney
samples. To more carefully study the relative abundance of eNOS and
nNOS mRNA expression during postnatal renal maturation, experiments
were performed on samples obtained from the same kidney. RT-PCR
analysis of eNOS and nNOS mRNA gene expression therefore was performed
on newborn and 7-day-old piglets and adult pigs. cDNA from eNOS and
nNOS were used as positive control to distinguish the PCR product of
eNOS and nNOS. As shown in Fig. 4, in the
newborn kidney, both eNOS and nNOS are expressed at a high level.
However, at day 7 mRNA level of eNOS dramatically decreases,
whereas mRNA level of nNOS only slightly decreases. As described in our
previous studies on nNOS expression during renal maturation,
(22) the mRNA level of nNOS decreases to the lowest level
in the adult kidney. In contrast, mRNA levels of eNOS in the adult
returns to the same high level as in the newborn kidney.
|
| |
DISCUSSION |
|---|
|
|
|---|
These studies are the first to describe eNOS expression in the postnatal developing kidney. Both whole kidney eNOS mRNA and protein content demonstrate parallel changes throughout the period of renal maturation. From a high level at birth, the expression of this isoform rapidly decreases to its lowest point at 7 days of age. Thereafter, eNOS abundance increases to approximate the newborn and is sustained at this level to the adult. The developmental pattern of eNOS contrasts with that of nNOS. Experiments in this study also demonstrate the mRNA expression of the two isoforms in the same kidney sample. In contrast to the fluctuating eNOS levels that return to adult equivalent levels during maturation, nNOS remains greater than the adult throughout renal development. The findings in this series of experiments confirm our previous description of nNOS mRNA and protein expression in the postnatal kidney performed in separate samples at ages representative of the entire developmental spectrum (22). Given the developmental differences between whole kidney eNOS and nNOS, the timing of their contribution to NO function during renal maturation may differ as well. Whereas nNOS may undergo regulation and may participate in renal function throughout the period of renal development, the most important impact of eNOS may occur in a narrower postnatal window, in the first days of the maturing kidney.
Critical changes occur in renal function after birth. Compared with the adult, the newborn kidney has low RBF and low GFR because of the high renal vascular resistance (RVR) produced by highly activated vasoconstrictors. Synchronous increases in RBF and GFR ensue during development, mediated by decreases in RVR in the intrarenal resistance vessels (21). The most abrupt hemodynamic changes occur immediately after birth, with a rapid rise in RBF and GFR. In the newborn kidney, although overall RBF is low, cortical blood flow is proportionately greater than in the adult. As RBF abruptly increases in the early neonatal period, most of the increase occurs in the cortex. Thereafter, continued maturation of renal hemodynamics proceeds progressively with age to adult capability. Compared with the adult, NO has a greater role in immature renal function (21). Functioning as a vasodilator, NO counterbalances highly activated vasoconstrictor mechanisms, such as the renin angiotensin system (20, 23). In the adult kidney, eNOS is strategically located in afferent and efferent arterioles (1, 12, 25) to modulate cortical renal hemodynamics. Thus increased cortical amounts of eNOS at birth would further support the timing of eNOS participation at this time of development.
Indeed, our studies show that eNOS undergoes differential changes in cortical and medullary expression during renal development. In the newborn and 7-day-old kidney, cortical eNOS protein content is greater than medullary, a pattern that is different in the adult with cortical and medullary eNOS expression almost the same. Also, the newborn demonstrates the largest abundance of cortical eNOS, whereas the adult has relatively equivalent amounts of cortical and medullary eNOS protein. The changing corticomedullary patterns of eNOS in the immature kidney are of particular interest in light of recent descriptions of medullary eNOS in the adult rat under basal and stimulated conditions and our previous studies of nNOS corticomedullary changes during development. NOS enzymatic activity, without distinguishing between the individual isoforms in normal adult rats, is greatest in the medulla (27). With specific regard to medullary eNOS, in the normal adult rat, Mattson and Higgins (15) reported increased medullary expression of this isoform. Wu et al. (27) demonstrated increased levels of eNOS mRNA in not only the vasa recta, but also in the inner medullary collecting duct, both of which were greater than cortical eNOS. Although cortical and medullary eNOS was approximately the same under basal conditions in untreated rats, deoxycortisone acetate treatment of normal rats increased both cortical and medullary eNOS, with most of the medullary increase occurring in tubular structures (16). Furthermore, the corticomedullary pattern of eNOS during renal development also differs from nNOS. We have reported previously that at all ages studied, newborn, 14-day-old piglets, and adult pigs, nNOS medullary expression was greater than cortical. The medullary expression was proportionately the greatest in the newborn, at the time that whole kidney nNOS is the most abundant (22). The cortical predominance of eNOS in the newborn and during the first days after birth supports the possibility that eNOS is a critical participant in cortical renal hemodynamics immediately after birth.
Both whole kidney and corticomedullary eNOS expression undergo
developmental regulation during postnatal renal maturation. However,
this developmental pattern of eNOS differed from nNOS. This observation
is consistent with our previous descriptions of nNOS in postnatal renal
development (22). These differences between the two NOS
isoforms suggest that they are regulated either by different factors or
by different mechanisms. Potential factors relevant to the regulation
of eNOS in the developing kidney include cell growth and proliferation,
hormones, such as estrogen, growth factors, and vasoconstrictors, such
as angiotensin II. The state of cell growth influences eNOS expression;
however, the direction of eNOS change remains disputed. Most studies
report an upregulation of eNOS mRNA in proliferating cells associated
with no change in transcription rates but a posttranscriptional
stabilization of mRNA (8, 18). Immediately after birth the
newborn has high levels of estrogen and estrogen receptors
(10). Estrogen upregulates eNOS mRNA and protein
expression in a variety of experimental situations (8),
perhaps from increased gene transcription (26). Two growth
factors appear to regulate eNOS. Transforming growth factor-
1, which
is highly expressed during renal development (2, 6)
upregulates eNOS when applied directly to cell cultures or when
stimulated by high salt diet (8, 28). Also, vascular endothelial growth factor (VEGF)-A, a participant in the formation of
glomerular vessels, upregulates eNOS in cell culture (3, 14) through the VEGF receptor-2 (14). Angiotensin
II regulates eNOS in adult rat renal resistance arterioles, perhaps via
the AT-1 receptor subtype (24). To further understand the
role of eNOS in the immature kidney, studies are needed to localize
eNOS in the immature kidney, quantify it in selective nephron
components in the cortex and medulla, and examine mechanisms producing
its unique regulatory pattern.
In summary, eNOS mRNA and protein expression demonstrate distinct parallel changes during the early period of postnatal renal maturation, dipping from newborn levels to a low at 7 days and then returning to newborn and adult equivalent abundance. This contrasts to the developmental pattern of nNOS, which is greatest at birth, then progressively declines though the period of renal maturation to the lowest levels in the adult. At birth and in the early days of development, cortical expression is greater than medullary, compared with the adult, in which cortical and medullary eNOS are relatively the same.
In conclusion, eNOS undergoes both whole kidney and corticomedullary developmental regulation in the early postnatal renal maturation and may critically participate in renal hemodynamics of the immature kidney during this period of development. The contrasting patterns between eNOS and nNOS suggest that these isoforms may be regulated by different mechanisms and may contribute to NO function differently during renal maturation.
Perspectives
NO functions as a vital vasodilator in the immature kidney, functioning to counterbalance highly activated vasoconstrictor systems to maintain RBF and GFR. However, how and when NO participates in maturing renal hemodynamics is not well understood. The discovery that eNOS renal expression undergoes developmental changes in the first few days after birth provides a clue into the role of NO immediately after birth. This isoform may function to critically maintain cortical renal function in the immediate newborn period, when renal hemodynamics are changing rapidly. Because the renal expression of eNOS differs from nNOS, further investigation of these isoforms is needed to identify the mechanisms producing their developmental regulation and their roles during postnatal renal development.| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant IRO1-HL-52765 to M. J. Solhaug and in part by a grant from the Jeffress Foundation, Richmond, VA.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. J. Solhaug, Eastern Virginia Medical School, PO Box 1980 Norfolk, VA 23501-1980 (E-mail: solhaumj{at}.evms.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 7 August 2000; accepted in final form 6 December 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bachmann, S,
Bosse HM,
and
Mundel PM.
Topography and nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F885-F898,
1995
2.
Basile, DP,
and
Hammerman MR.
TGF-beta in renal development and renal growth.
Miner Electrolyte Metab
24:
144-148,
1998[ISI][Medline].
3.
Bouloumie, A,
Schini-Kerth VB,
and
Busse R.
Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells.
Cardiovasc Res
41:
773-780,
1999[ISI][Medline].
4.
Braam, B,
Turkstra E,
and
Koomans HA.
Concerted actions of renal endothelial and macula densa NO systems in the maintenance of extracellular fluid volume.
Acta Physiol Scand
168:
125-132,
2000[ISI][Medline].
5.
Cathala, G,
Savouret J-F,
Mendez B,
West BL,
Karin M,
Martial JA,
and
Baxter JD.
Laboratory methods: a method for isolation of intact, translationally active ribonucleic acid.
DNA (NY)
2:
329-335,
1983[ISI][Medline].
6.
Choi, ME,
Liu A,
and
Ballerman BJ.
Differential expression of transforming growth factor-beta receptors in rat kidney development.
Am J Physiol Renal Physiol
273:
F386-F395,
1997
7.
Fischer, E,
Schnermann J,
Briggs JP,
Kriz W,
Ronco PM,
and
Bachmann S.
Ontogeny of NO synthase and renin in the juxtaglomerular apparatus of rat kidneys.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F1164-F1176,
1995
8.
Förstermann, U,
Boissel JP,
and
Kleinert H.
Expressional control of the `constitutive' isoforms of nitric oxide synthase (NOS I and NOS III).
FASEB J
12:
773-790,
1998
9.
Granger, JP,
Alberola AM,
Salazar FJ,
and
Nakamura T.
Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs.
J Cardiovasc Pharmacol
20, Suppl:
S160-S162,
1992.
10.
Hagenfeldt, Y,
and
Eriksson HA.
The estrogen receptor in the rat kidney. Ontogeny, properties and side effects of gonadectomy on its concentration.
J Steroid Biochem
31:
49-56,
1998.
11.
Ito, S,
and
Ren Y.
Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics.
J Clin Invest
92:
1093-1098,
1993.
12.
Kone, BC.
Localization and regulation of nitric oxide synthase isoforms in the kidney.
Semin Nephrol
19:
230-241,
1999[ISI][Medline].
13.
Kone, BC,
and
Baylis C.
Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.
Am J Physiol Renal Physiol
272:
F561-F578,
1997
14.
Kroll, J,
and
Waltenberger J.
VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
Biochem Biophys Res Commun
27:
743-746,
1998.
15.
Mattson, D,
and
Higgins DJ.
Influence of dietary sodium intake on renal medullary nitric oxide synthase.
Hypertension
27:
688-692,
1996
16.
Pollock, GH,
Hukkanen M,
Polak JM,
Pollock JS,
and
Pollock DM.
Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats.
J Am Soc Nephrol
10:
2283-2289,
1999
17.
Schnackenberg, CG,
Wilkins FC,
and
Granger JP.
Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs.
Hypertension
26:
1024-1029,
1995
18.
Searles, CD,
Miwa Y,
Harrison DG,
and
Ramasamy S.
Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.
Circ Res
85:
588-595,
1999
19.
Sigmon, DH,
Newman JM,
and
Beierwaltes WH.
Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats.
J Am Soc Nephrol
4:
1675-1682,
1994[Abstract].
20.
Simeoni, U,
Zhu B,
Muller C,
Judes C,
Massfelder T,
Geisert J,
and
Helwig JJ.
Postnatal development of vascular resistance of the rabbit isolated perfused kidney: modulation by nitric oxide and angiotensin II.
Pediatr Res
42:
550-555,
1997[ISI][Medline].
21.
Solhaug, MJ,
Ballèvre LD,
Guignard J-P,
Granger JP,
and
Adelman RD.
Nitric oxide in the developing kidney.
Pediatr Nephrol
10:
529-539,
1996[ISI][Medline].
22.
Solhaug, MJ,
Dong X,
Adelman RD,
and
Dong KW.
Ontogeny of neuronal nitric oxide synthase, NOS 1, in the developing porcine kidney.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R1453-R1459,
2000
23.
Solhaug, MJ,
Wallace MR,
and
Granger JP.
Nitric oxide and angiotensin II regulation of renal hemodynamics in the developing piglet.
Pediatr Res
39:
527-533,
1996[ISI][Medline].
24.
Thorup, C,
Kornfield M,
Winaver JM,
Goligorsky MS,
and
Moore LC.
Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
Pflügers Arch-Eur J Physiol
435:
432-434,
1998[ISI][Medline].
25.
Ujiie, K,
Yuen J,
Hogarth L,
Danziger R,
and
Star RA.
Localization and regulation of endothelial NO synthase. mRNA expression in rat kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F296-F302,
1994
26.
Wang, X,
Barber DA,
Lewis DA,
McGregor CG,
Sieck GC,
Fitzpatrick LA,
and
Miller VM.
Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells.
Am J Physiol Heart Circ Physiol
273:
H1962-H1967,
1997.
27.
Wu, F,
Park F,
Cowley AW, Jr,
and
Mattson DL.
Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney.
Am J Physiol Renal Physiol
276:
F874-F881,
1999
28.
Ying, WZ,
and
Sanders PW.
Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta1.
Am J Physiol Renal Physiol
275:
F18-F24,
1998
This article has been cited by other articles:
![]() |
A. Patzak, A. Steege, E. Y. Lai, J. O. Brinkmann, E. Kupsch, N. Spielmann, A. Gericke, A. Skalweit, J. Stegbauer, P. B. Persson, et al. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R429 - R437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Han, J.-M. Lim, W.-Y. Kim, H. Kim, K. M. Madsen, and J. Kim Expression of endothelial nitric oxide synthase in developing rat kidney Am J Physiol Renal Physiol, April 1, 2005; 288(4): F694 - F702. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Persson Nitric oxide in the kidney Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1005 - R1007. [Full Text] [PDF] |
||||
![]() |
H. Ehmke Developmental physiology of the cardiovascular system Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R331 - R333. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |